BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25022976)

  • 1. Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: multidetector computed tomography versus magnetic resonance imaging.
    Zhao L; Ma X; Feuchtner GM; Zhang C; Fan Z
    Eur J Radiol; 2014 Oct; 83(10):1778-85. PubMed ID: 25022976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
    Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
    J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of computed tomography for detection of concomitant coronary disease in hypertrophic cardiomyopathy.
    Zhao L; Ma X; Ge H; Zhang C; Wang Z; Teraoka K; Fan Z
    Eur Radiol; 2015 Mar; 25(3):767-75. PubMed ID: 25358595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia.
    Kwon DH; Smedira NG; Rodriguez ER; Tan C; Setser R; Thamilarasan M; Lytle BW; Lever HM; Desai MY
    J Am Coll Cardiol; 2009 Jul; 54(3):242-9. PubMed ID: 19589437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
    Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of healed myocardial infarction with multidetector-row computed tomography and comparison with cardiac magnetic resonance delayed hyperenhancement.
    Sanz J; Weeks D; Nikolaou K; Sirol M; Rius T; Rajagopalan S; Dellegrottaglie S; Strobeck J; Fuster V; Poon M
    Am J Cardiol; 2006 Jul; 98(2):149-55. PubMed ID: 16828583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Dimensions in Children With Hypertrophic Cardiomyopathy: A Comparison Between Echocardiography and Cardiac Magnetic Resonance Imaging.
    Windram JD; Dragelescu A; Benson L; Forsey J; Shariat M; Yoo SJ; Mertens L; Wong D; Grosse-Wortmann L
    Can J Cardiol; 2016 Dec; 32(12):1507-1512. PubMed ID: 27789109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiography scar quantification correlates with scar size of hypertrophic cardiomyopathy seen by multidetector computed tomography.
    Bignoto TC; Moreira DAR; Habib RG; de Barros Correia E; Amarante RC; Jatene T; Nunes MBG; Senra T; Mastrocolla LE
    Clin Cardiol; 2018 Jun; 41(6):837-842. PubMed ID: 29671882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients.
    Suk T; Edwards C; Hart H; Christiansen JP
    Heart Lung Circ; 2008 Oct; 17(5):370-4. PubMed ID: 18562248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated assessment of heart chamber volumes and function in patients with previous myocardial infarction using multidetector computed tomography.
    Fuchs A; Kühl JT; Lønborg J; Engstrøm T; Vejlstrup N; Køber L; Kofoed KF
    J Cardiovasc Comput Tomogr; 2012; 6(5):325-34. PubMed ID: 23040538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidetector computed tomography in reperfused acute myocardial infarction. Assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging.
    Jacquier A; Boussel L; Amabile N; Bartoli JM; Douek P; Moulin G; Paganelli F; Saeed M; Revel D; Croisille P
    Invest Radiol; 2008 Nov; 43(11):773-81. PubMed ID: 18923256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic substrate detection in chronic ischaemic patients undergoing ventricular tachycardia ablation using multidetector cardiac computed tomography: compared evaluation with cardiac magnetic resonance.
    Jáuregui B; Soto-Iglesias D; Zucchelli G; Penela D; Ordóñez A; Terés C; Chauca A; Acosta J; Fernández-Armenta J; Linhart M; Perea RJ; Prat-González S; Bosch X; Ortiz-Pérez JT; Mont L; Berruezo A
    Europace; 2021 Jan; 23(1):82-90. PubMed ID: 33038230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating global and regional left ventricular function in patients with reperfused acute myocardial infarction by 64-slice multidetector CT: a comparison to magnetic resonance imaging.
    Sarwar A; Shapiro MD; Nasir K; Nieman K; Nomura CH; Brady TJ; Cury RC
    J Cardiovasc Comput Tomogr; 2009; 3(3):170-7. PubMed ID: 19527893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of magnetic resonance myocardial delayed enhancement.
    Zhang ZH; Miao Q; Lin SB; Zhang SY; Li DJ; Chen LB; Zhang H; Wang YN; Zhou L; Kong LY; Feng F; You H; Sun HY; Zhao WM; Zhang LR; Jin ZY
    Chin Med Sci J; 2006 Dec; 21(4):245-51. PubMed ID: 17249200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography.
    Zhao L; Ma X; Delano MC; Jiang T; Zhang C; Liu Y; Zhang Z
    Eur Radiol; 2013 Apr; 23(4):1034-43. PubMed ID: 23064716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients.
    Langer C; Lutz M; Eden M; Lüdde M; Hohnhorst M; Gierloff C; Both M; Burchert W; Faber L; Horstkotte D; Frey N; Prinz C
    Int J Cardiovasc Imaging; 2014 Mar; 30(3):659-67. PubMed ID: 24449335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cardiovascular disease in elite athletes using cardiac magnetic resonance imaging.
    Mangold S; Kramer U; Franzen E; Erz G; Bretschneider C; Seeger A; Claussen CD; Niess AM; Burgstahler C
    Rofo; 2013 Dec; 185(12):1167-74. PubMed ID: 23897528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Cardiac Magnetic Resonance Imaging to Measure Left Ventricular Wall Thickness for Determining Risk Scores for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
    Webb J; Villa A; Bekri I; Shome J; Teall T; Claridge S; Jackson T; Porter B; Ismail TF; Di Giovine G; Rinaldi CA; Carr-White G; Al-Fakih K; Razavi R; Chiribiri A
    Am J Cardiol; 2017 May; 119(9):1450-1455. PubMed ID: 28267963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
    Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.